Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

University of North Carolina

BioCentury | Sep 6, 2024
Distillery Therapeutics

Small molecule un-silencer of UBE3A for Angelman syndrome

BioCentury | Aug 14, 2024
Discovery & Translation

Science Spotlight: Reducing HIV load, new glycopeptide antibiotics, and more

BioCentury’s roundup of translational innovations
BioCentury | Aug 1, 2024
Distillery Therapeutics

Engineered long-acting S. boulardii yeast for IBD

BioCentury | Jun 5, 2024
Regulation

FDA panel snubs Lykos’ MDMA therapy, not psychedelics generally

Committee advisers weren’t convinced Lykos’ psychotherapy combination is either effective or safe for PTSD
BioCentury | Feb 29, 2024
Regulation

Ultrarare inflection point: stakeholders argue for biomarker-based approvals

Reagan-Udall Foundation meeting on biomarkers could change FDA policy on neuronal MPS endpoints, unleash approvals
BioCentury | Feb 20, 2024
Distillery Therapeutics

PTGER4 antagonist with novel scaffold for pain

BioCentury | Dec 15, 2023
Discovery & Translation

GDF15 linked to severe nausea in pregnancy; plus Carvykti mechanism and more

BioCentury’s roundup of translational innovations
BioCentury | Nov 16, 2023
Discovery & Translation

Aldena’s JAK-1-selective siRNA; an aerosol mAb for SARS-CoV-2 and more

BioCentury’s roundup of translational innovations
BioCentury | Oct 6, 2023
Discovery & Translation

An AbbVie-Calico cancer therapy; plus Moderna’s monkeypox vaccine and more

BioCentury’s roundup of translational innovations
Items per page:
1 - 10 of 396